Skip to main content

Table 2 Demographic and baseline characteristics of the study population by limb lengthening

From: Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study

 

Subgroup

 

LL: Yes (N = 40)

LL: No (N = 146)

Country of enrolment, n (%)

 Denmark

1 (2.5)

9 (6.2)

 Germany

6 (15.0)

58 (39.7)

 Sweden

0

9 (6.2)

 Austria

0

3 (2.1)

 Italy

19 (47.5)

38 (26.0)

 Spain

14 (35.0)

29 (19.9)

Age, n (%)

 Mean (SD)

24.2 (12.6)

21.0 (18.4)

 Median (Q1, Q3)

18.5 (14.7, 36.8)

13.1 (8.0, 26.8)

 Min, Max

7.4, 51.4

5.0, 84.4

Age subgroups at enrolment (years), n (%)

 5–10

4 (10.0%)

62 (42.5%)

 11–15

10 (25.0%)

26 (17.8%)

 16–20

8 (20.0%)

9 (6.2%)

 21–30

5 (12.5%)

17 (11.6%)

 31–40

7 (17.5%)

7 (4.8%)

 41–50

5 (12.5%)

10 (6.8%)

 51–60

1 (2.5%)

7 (4.8%)

  > 60

0 (0.0%)

8 (5.5%)

Gender, n (%)

 Male

10 (25.0%)

75 (51.4%)

 Female

30 (75.0%)

71 (48.6%)

Time Since LL (years)

 N

36

 Missing

4

 Mean (SD)

8.4 (9.7)

 Median (Q1, Q3)

3.5 (1.0, 16.0)

 Min, Max

0.0, 28.0

  1. LL Limb lengthening, max Maximum, min Minimum, Q1 First quartile, Q3 Third quartile, SD Standard deviation